C84.92
Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Mature T/NK-cell lymphomas are a group of blood cancers originating from T lymphocytes and natural killer (NK) cells. When these lymphomas develop within the intrathoracic lymph nodes—located within the chest cavity—they can cause a range of health issues. ICD-10 code C84.92 specifically refers to these lymphomas when the diagnosis is unspecified within this category. These types of lymphomas are relatively rare but can be aggressive, requiring prompt medical attention for diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting lymphocyte development Chronic immune stimulation or inflammation Exposure to certain chemicals or environmental toxins Viral infections, such as Epstein-Barr virus (EBV) or Human T-cell lymphotropic virus (HTLV) History of other hematologic malignancies
Key Symptoms: Chest pain or discomfort Persistent cough or shortness of breath Swelling or enlargement of lymph nodes within the chest Unexplained weight loss Fever and night sweats Fatigue or weakness Frequent infections due to immune system compromise
Diagnostic & Treatment
Diagnosis Path: {'medical history and physical examination': 'Assessment of symptoms and physical signs such as lymph node swelling.', 'Imaging tests': ['Chest X-ray to visualize the intrathoracic area', 'Computed Tomography (CT) scans for detailed images of the chest cavity', 'Positron Emission Tomography (PET) scans to identify active cancerous areas'], 'biopsies': ['Lymph node biopsy to examine tissue under a microscope', 'Bone marrow biopsy if spread is suspected'], 'laboratory tests': ['Blood tests to evaluate blood cell counts and look for specific markers', 'Molecular and genetic tests to identify lymphoma subtypes']}
Treatment Protocols: {'chemotherapy': 'Use of powerful drugs to kill cancer cells, often the mainstay of treatment.', 'radiation therapy': 'Targeted radiation to destroy localized cancerous tissue within the chest.', 'targeted therapy': 'Medications designed to target specific genetic or molecular features of the lymphoma.', 'immunotherapy': "Boosting the body's immune response to fight the lymphoma, including monoclonal antibodies.", 'stem cell transplant': 'High-dose chemotherapy followed by transplant of healthy stem cells, considered in aggressive or refractory cases.', 'supportive care': 'Managing symptoms and side effects, maintaining nutritional status, and preventing infections.'}
Clinical Advice & FAQs
Billing Guidance
Is C84.92 a billable ICD-10 code?
Yes, C84.92 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.92?
Clinical documentation must specify the nature of Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
